Abstract: The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central nervous system diseases, FAM19A5 being spread in the neural stem cells in vertebrates and regulating gliogenesis.

Abstract: A method of a terminal, according to an exemplary embodiment of the present disclosure, may include: requesting access to a mobile integrated access backhaul (IAB) based on cell search; receiving a tracking area (TA) update procedure stop request message from an Access and Mobility Management Function (AMF) of a core network; and deactivating a TA update procedure based on the TA update procedure stop request message.

Abstract: A method of an IAB node may comprise: receiving an RRC message including measurement control information from a base station; transmitting RRC reconfiguration information including the measurement control information to each of a plurality of terminals; receiving a measurement report message including a measurement report generated by each of the plurality of terminals based on the measurement control information from each of the plurality of terminals; and grouping the measurement report messages received from the plurality of terminals into a grouped message report message, and transmitting the grouped measurement report message to the base station according to a grouped measurement reporting periodicity.

Abstract: A method of an integrated access and backhaul (IAB) node may include: receiving, from a target base station, one or more user equipment (UE) context setup request messages including terminal radio resource reconfiguration information; sharing context information including the terminal radio resource reconfiguration information with a source IAB-distributed unit 1 (IAB-DU1); configuring terminal reconfiguration information using the shared context information; and transmitting one or more UE context setup response messages including the terminal reconfiguration information to the target base station in response to the one or more UE context setup request messages.

Abstract: A display device may include a first electrode, a second electrode, an emission layer, an intervening layer, and a first encapsulation layer. The second electrode may overlap the first electrode. The emission layer may be disposed between the first electrode and the second electrode, may overlap the first electrode, and may include a light emitting material. The intervening layer may directly contact the second electrode, may be spaced from each of the first electrode and the emission layer, and may include a fluorine compound. A first section of the first encapsulation layer may overlap the emission layer. The intervening layer may be positioned between the second electrode and a second section of the first encapsulation layer.

Abstract: A complementary thin film transistor (TFT) includes a substrate and a first TFT and a second TFT disposed on the substrate, wherein a first conductive semiconductor layer of the first TFT and a second gate electrode layer of the second TFT are disposed in the same layer and include the same material.

Abstract: The present invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, which comprises administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising an isoxazole derivative, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt of the derivative, the racemate, the enantiomer, or the diastereoisomer.

Abstract: The present invention relates to a display substrate and a method for manufacturing same. More specifically, the present invention provides a display substrate in which an electrical connection portion between a display sheet and a peripheral component electrically connected to the display sheet has improved heat resistance and durability, and a method for manufacturing same. A display substrate according to the present invention includes: a flexible substrate on which a plurality of light-emitting elements is arranged; and a wiring portion which is formed on one surface of the flexible substrate and supplies power to the light-emitting elements.

Abstract: An optical sheet includes a base film in which light is incident from a lower side, a plurality of prism patterns and a diffusion member. The prism patterns are protruded to be spaced apart from each other on the base film to enhance the front luminance of light incident from the lower side of the base film. The diffusion member is disposed between prism patterns to have a diffusion surface in parallel with the base film. The diffusion member includes a plurality of diffusion dots capable of enhancing the luminance uniformity of light incident from the lower side of the base film. Thus, front luminance and luminance uniformity may be enhanced due to a juxtaposition of the prism patterns and the diffusion portion, and the viewing angle of the LCD device may be enhanced.

Abstract: An optical sheet includes a base film in which light is incident from a lower side, a plurality of prism patterns and a diffusion member. The prism patterns are protruded to be spaced apart from each other on the base film to enhance the front luminance of light incident from the lower side of the base film. The diffusion member is disposed between prism patterns to have a diffusion surface in parallel with the base film. The diffusion member includes a plurality of diffusion dots capable of enhancing the luminance uniformity of light incident from the lower side of the base film. Thus, front luminance and luminance uniformity may be enhanced due to a juxtaposition of the prism patterns and the diffusion portion, and the viewing angle of the LCD device may be enhanced.